ISSN: 2155-6105

Journal de recherche et de thérapie en toxicomanie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Indice source CAS (CASSI)
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Clés académiques
  • JournalTOC
  • SécuritéLit
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

A Comparison of Suboxone and Methadone in the Treatment of Opiate Addiction

Adam N Peddicord, Chris Bush and Crystal Cruze

Background: The rate of drug dependence and abuse is a growing problem in the United States. Since 1990, the rate of death from drug overdoses has tripled. According to the Center for Disease Control, for every one drug overdose there are 130 people that abuse or are dependent on drugs. Opiates are the primary drug class that is abused and there is a great need to identify effective treatment options.
Method: A review of the literature was conducted using articles regarding opiate addiction and treatment that were published between 2009-2014 in peer-reviewed journals.
Results: Suboxone and methadone are both proven to be effective treatment options. Both medications have unique risks and benefits, and the research does not indicate that one medication is a better option than the other. This decision must be based on an individual basis after reviewing important patient factors such as health status and access to the medication.
Conclusion: Suboxone and methadone each have their own advantages and disadvantages. When choosing an appropriate medication, many factors must be considered, such as dosing schedule, side effects, risk of abuse and overdose, and cost. The choice must be made as a collaborative effort between the provider and the patient to choose the most appropriate and effective medication.